US Agency Broadens Coverage Of Personalis Breast Cancer Test
Personalis Inc PSNL
$8.47
▲ +2.67%
(+$0.22)
Open
$8.35
Prev Close
$8.25
Day Range
$8.05 – $8.69
52W Range
$3.84 – $11.50
Market Cap
$886.99M
Beta
2.06
EPS (TTM)
$-1.02
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-06-20 |
| Shares Out. | 104,720,000 |
| Website | personalis.com/ ↗ |
| Phone | 13025310855 |
Personalis Inc is a publicly traded company under the ticker symbol PSNL on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-05-01)
📰 Latest News for PSNL
Personalis to Participate in Upcoming Investor Events
Personalis Inc Receives Medicare Coverage for Next Personal for Immunotherapy Monitoring Across Late-Stage Solid Tumors
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Personalis receives Medicare coverage for Next Personal for immunotherapy monitoring across late-stage solid tumors
Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors
Morgan Stanley Maintains Equal-Weight on Personalis, Lowers Price Target to $9
BTIG Maintains Buy on Personalis, Lowers Price Target to $11